V.Yu. Aleksenko et al. / Polyhedron 51 (2013) 168–179
177
2
(400.13 MHz, CDCl3, d/ppm, J/Hz): 3.33 (dd, 1 H, CH2, JPH = 5.4,
H
Ar). 13C{1H} NMR (100.61 MHz, CDCl3, d/ppm, J/Hz): 46.13 (d,
CH2, JPC = 43.8), 123.48 (d, C4, JPC = 13.2), 126.19 (d, ipso-C in
2JHH = 14.2), 4.92 (dd, 1 H, CH2, JPH = 22.3, JHH = 14.2), 6.99 (dd,
2
2
1
3
3
3
3
1
1
1 H, H–C3, JPH = 15.6, JHH = 7.8), 7.07 (dt, 1 H, H–C4, JHH = 7.8,
CH2P(S)C6H5, JPC = 80.3), 126.49 (d, C2, JPC = 102.3), 126.62 (d,
4JPH = 3.1), 7.35–7.63 (m, 16 H, HAr), 7.71 (t,
1
1
H, H–C5,
H, H–C6,
m
ipso-C in ArP(O)C6H5, JPC = 111.5), 126.90 (d, ipso-C in CH2P(S)-
C6H5, JPC = 86.2), 128.50 (d, m-C in P(X)C6H5, JPC = 13.5), 128.64
(d, m-C in P(X)C6H5, JPC = 13.2), 128.87 (d, C6, JPC = 7.3), 129.04
1
3JHH = 7.9), 7.77–7.86 (m,
4
H, HAr), 8.20 (dd,
1
3
4
3
3
3JHH = 7.9, JPH = 4.9), 10.59 (br. s, 1 H, NH). IR (RBr,
/cmꢁ1):
1
513(w), 528(m), 550(m), 692(m), 708(w), 722(m), 734(w),
744(m), 750(m), 838(w), 998(w), 1028(w), 1072(w), 1106(m),
1122(m), 1147(m) and 1158(m) (P@O in ArP(O)Ph2), 1171(m)
and 1185(m) (P@O in CH2P(O)Ph2), 1255(w), 1297(m), 1388(w),
1438(s), 1461(w), 1485(w), 1529(m), 1578(m), 1590(w),
1598(w), 1696(m) (C@O), 1877(vs) (CO), 1883(vs) (CO), 1896(vs)
(CO), 1902(vs) (CO), 2020(vs) (CO), 2895(w), 2952(w), 3059(w),
3287(w) (NH). Anal. Calc. for C35H27BrNO6P2Re: C, 47.47; H, 3.07;
Br, 9.02; N, 1.58; P, 7.10. Found: C, 47.37; H, 2.97; Br, 9.02; N,
1.47; P, 7.14%.
(d, ipso-C in ArP(O)C6H5, JPC = 108.4), 129.24 (d, m-C in P(X)C6H5,
3JPC = 12.8), 129.35 (d, m-C in P(X)C6H5, JPC = 12.8), 131.78 (d, o-
3
2
2
C in P(X)C6H5, JPC = 11.0), 131.80 (d, o-C in P(X)C6H5, JPC = 11.0),
132.04 (d, o-C in P(X)C6H5, JPC = 11.0), 132.27 (d, C3, JPC = 11.0),
2
2
4
132.59 (d, p-C in P(X)C6H5, JPC = 2.9), 133.00 (d, o-C in P(X)C6H5,
2JPC = 10.6), 133.07 (d, p-C in P(X)C6H5, JPC = 2.9), 133.25 (d, p-C
4
4
4
in P(X)C6H5, JPC = 3.3), 133.28 (d, p-C in P(X)C6H5, JPC = 2.9),
4
2
134.06 (d, C5, JPC = 1.8), 150.73 (d, C1, JPC = 1.5), 164.92 (d, C@O,
2JPC = 6.2). IR (RBr, /cmꢁ1): 516(w), 550(m), 564(s) (P@S),
m
582(w), 691(m), 717(m), 732(m), 747(m), 751(m), 836(w),
893(w), 988(w), 998(w), 1026(w), 1056(m), 1085(w), 1105(m),
1123(s) (P@O), 1193(w), 1267(w), 1311(w), 1347(m), 1375(w),
1437(s), 1462(m), 1483(w), 1562(w), 1580(m), 1615(vs) (C@O),
2850(w), 3054(w). Analytically pure sample was obtained upon
4.8. General procedure for the synthesis of Pd(II) complexes 6b–d
A solution of (PhCN)2PdCl2 (66 mg, 0.172 mmol) in 5 mL of
dichloromethane was slowly dropwise added to a solution of the
corresponding ligand (2b, 2c or 2d) (0.172 mmol) in 5 mL of
CH2Cl2. The reaction mixture was left under ambient conditions
for 12 h, then the solvent was removed in vacuo and the resulting
residue was purified by column chromatography on silica gel
(eluent CHCl3) to give 6b–d as orange crystalline solids.
recrsytallization from CH2Cl2–he[ane (1:2). Anal. Calc. for C32H26
-
ClNO2P2PdS: C, 55.51; H, 3.78; N, 2.02. Found: C, 55.14; H, 3.67;
N, 1.93%.
4.8.3. Complex 6d
Yield: 111 mg (91%). Mp: >285 °C (decomp.). 31P{1H} NMR
(121.49 MHz, CDCl3, d/ppm): 38.17 (CH2P(S)(C6H5)2), 41.04
(ArP(S)(C6H5)2). 1H NMR (400.13 MHz, CDCl3, d/ppm, J/Hz): 3.28
4.8.1. Complex 6b
Yield: 95 mg (80%). Mp: >230 °C (decomp.). 31P{1H} NMR
(161.98 MHz, CDCl3, d/ppm): 37.70 (CH2P(O)(C6H5)2), 47.23
(ArP(S)(C6H5)2). 1H NMR (400.13 MHz, CDCl3, d/ppm, J/Hz): 3.00
(dd, 1 H, CH2, JPH = 9.5, JHH = 13.3), 3.73 (dd, 1 H, CH2,
2
2
2JPH = 17.0, 2JHH = 13.3), 6.80 (dd,
1
H, H–C3, 3JHH = 7.7,
3JPH = 14.0), 7.02 (dt, 1 H, H–C4, JHH = 7.6, JPH = 3.6), 7.18 (dd, 1
3
4
2
2
3
4
(d,
1
H, CH2, JHH = 14.6), 3.84 (dd,
1
H, CH2, JHH = 14.6,
H, H–C6, JHH = 7.5, JPH = 5.2), 7.45–7.57 (m, 11 H, HAr), 7.61–
2JPH = 19.7), 6.73–6.78 (m,
2
H, HAr), 7.00 (dt,
1
H, H–C4,
7.67 (m, 4 H, HAr), 7.74 (dd, 2 H, o-H in P(S)C6H5, JHH = 7.8,
3
3JHH = 7.7, JPH = 3.2), 7.40 (t, 1 H, H–C5, JHH = 7.6), 7.50–7.67 (m,
3JPH = 14.7), 7.81 (dd, 2 H, o-H in P(S)C6H5, JHH = 7.9, JPH = 13.7),
4
3
3
3
3
3
3
14 H, HAr), 7.73–7.76 (dd, 2 H, o-H in P(X)C6H5, JHH = 7.8,
7.93 (dd, 2 H, o-H in P(S)C6H5, JHH = 7.7, JPH = 14.2). 13C{1H}
3JPH = 14.8), 7.80–7.90 (m, 4 H, HAr). 13C{1H} NMR (100.61 MHz,
NMR (100.61 MHz, CDCl3, d/ppm, J/Hz): 46.61 (d, CH2,
1
3
1
CDCl3, d/ppm, J/Hz): 43.73 (d, CH2, JPC = 57.2), 123.11 (d, ipso-C
in ArP(S)C6H5, JPC = 85.1), 123.52 (d, C4, JPC = 13.2), 124.24 (d,
C2, JPC = 86.6), 126.41 (d, ipso-C in ArP(S)C6H5, JPC = 88.8),
127.55 (d, ipso-C in CH2P(O)C6H5, JPC = 104.7), 127.61 (d, ipso-C
1JPC = 44.0), 123.52 (d, C4, JPC = 13.2), 124.23 (d, C2, JPC = 84.7),
1
3
1
126.58 (d, ipso-C in ArP(S)C6H5, JPC = 87.3), 127.19 (d, ipso-C in
1
1
1
ArP(S)C6H5, JPC = 88.4), 127.75 (d, ipso-C in CH2P(S)C6H5,
1
1
1JPC = 82.2), 128.26 (d, ipso-C in CH2P(S)C6H5, JPC = 81.4), 128.67
1
3
in CH2P(O)C6H5, JPC = 104.9), 128.66 (d, m-C in P(X)C6H5,
(d, m-C in P(S)C6H5, JPC = 13.6), 129.09 (d, m-C in P(S)C6H5,
3JPC = 13.6), 128.82 (d, m-C in P(X)C6H5, JPC = 12.4), 129.05 (d, m-
3JPC = 12.5), 129.14 (d, m-C in P(S)C6H5, JPC = 12.8), 129.26 (d, m-
3
3
3
3
3
C
in P(X)C6H5, JPC = 13.6), 129.18 (d, m-C in P(X)C6H5,
C in P(S)C6H5, JPC = 13.2), 130.31 (d, C6, JPC = 8.1), 131.45 (d, C3,
3
2
2
3JPC = 12.8), 130.05 (d, C6, JPC = 8.1), 131.07 (d, C3, JPC = 8.8),
2JPC = 9.2), 131.75 (d, o-C in P(S)C6H5, JPC = 11.00), 131.96 (d, o-C
2
2
2
131.16 (d, o-C in P(X)C6H5, JPC = 10.6), 131.60 (d, o-C in
P(X)C6H5, JPC = 10.3), 132.03 (d, o-C in P(X)C6H5, JPC = 11.7),
in P(S)C6H5, JPC = 11.7), 132.00 (d, o-C in P(S)C6H5, JPC = 11.4),
2
2
4
132.64 (d, p-C in P(S)C6H5, JPC = 3.3), 132.87 (d, p-C in P(S)C6H5,
4
4
132.91 (d, p-C in P(X)C6H5, JPC = 2.6), 133.04 (s, p-C in P(X)C6H5),
4JPC = 3.3), 133.05 (d, p-C in P(S)C6H5, JPC = 2.9), 133.28 (d, p-C in
2
4
2
133.17 (s, p-C in P(X)C6H5), 133.48 (d, o-C in P(X)C6H5, JPC = 9.9),
P(S)C6H5, JPC = 2.9), 133.48 (d, o-C in P(S)C6H5, JPC = 10.3),
4
4
2
133.53 (s, p-C in P(X)C6H5), 133.94 (d, C5, JPC = 2.2), 151.14 (d,
134.09 (d, C5, JPC = 2.2), 151.14 (d, C1, JPC = 4.4), 165.56 (d,
2
2
2
C1, JPC = 3.7), 165.25 (d, C@O, JPC = 6.6). IR (RBr,
m
/cmꢁ1):
C@O, JPC = 6.6). IR (RBr, m
/cmꢁ1): 525(m), 548(m), 586(s) (P@S in
510(m), 517(s), 552(w), 594(m) (P@S), 619(w), 633(w), 691(m),
712(m), 723(w), 746(m), 752(m), 761(m), 795(w), 841(w),
982(w), 998(w), 1028(w), 1065(w), 1080(w), 1107(m), 1126(m),
1137(s) (P@O), 1163(w), 1189(w), 1264(w), 1329(s), 1378(w),
1437(s), 1462(m), 1483(w), 1560(w), 1576(m), 1590(w), 1616(vs)
(C@O), 2852(w), 2922(w), 3057(w). Anal. Calc. for C32H26ClNO2P2
PdS: C, 55.51; H, 3.78; N, 2.02. Found: C, 55.06; H, 3.64; N, 1.96%.
CH2P(S)(C6H5)2, 601(m) (P@S in ArP(S)(C6H5)2), 621(w), 633(w),
688(s), 703(m), 716(m), 745(s), 841(w), 892(w), 983(w), 988(w),
1027(w), 1071(w), 1104(s), 1186(w), 1265(w), 1314(w), 1337(br,
m), 1379 (w), 1437(s), 1462(m), 1481(w), 1577(m), 1609(s)
(C@O), 2910(w), 3054(w). Anal. Calc. for C32H26ClNOP2PdS2: C,
54.25; H, 3.70; N, 1.98. Found: C, 54.35; H, 3.88; N, 1.91%.
4.9. Crystal structure determination and data collection
4.8.2. Complex 6c
Yield: 55 mg (46%). Mp:>230 °C (decomp.). 31P{1H} NMR
(121.49 MHz, CDCl3, d/ppm): 43.30 (ArP(O)(C6H5)2), 46.90
(CH2P(S)(C6H5)2). 1H NMR (300 MHz, CDCl3, d/ppm, J/Hz): 3.45
Single crystals suitable for X-ray experiments were obtained by
recrystallization from ethanol (2a) or acetonitrile (2b) or slow dif-
fusion of hexane into CH2Cl2 (5, 6d) or CHCl3 (4a, 4d, 6b, 6c) solu-
tions. X-ray diffraction experiments were carried out with a SMART
1000 CCD diffractometer for compound 2a and with a SMART
APEX2 CCD diffractometer for 2b and complexes 4a, 4d, 5, 6b, 6c,
2
2
(dd,
1 H, CH2, JPH = 8.5, JHH = 14.0), 4.14 (dd, 1 H, CH2,
2
3
4
2JPH = 17.9, JHH = 14.0), 6.77 (dd, 1 H, H–C3, JHH = 7.7, JPH = 4.2),
3
3
6.86 (dd, 1 H, H–C6, JHH = 8.0, JPH = 13.4), 7.06 (dt, 1 H, H–C4,
4
3JHH = 7.7, JPH = 2.5), 7.41–7.65 (m, 17 H, HAr), 7.84–7.89 (m, 4 H,
and 6d, using graphite monochromated Mo Ka radiation